Minimally invasive surgery registry for bleeding in the brain
Part of Brain & nervous system clinical trials.
This study records and compares outcomes for people with a specific kind of sudden brain bleeding (intracerebral hemorrhage) using minimally invasive surgery. It may help doctors understand which patients benefit most and improve future care decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18 years
- A CT scan must show a new, spontaneous brain bleed above the brainstem (not in the brainstem) that is more than 20 mL
- Surgery must start within 24 hours of the last known normal time (or within 24 hours of waking up when symptoms started)
- Your baseline disability score (mRS) must be 2 or less before this event
- A blood vessel scan (CT angiography) must not show a malformation that caused the bleed
- You must be able to have required follow-up visits and assessments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who have had sudden, severe bleeding in the brain and received minimally invasive surgery (a less-invasive surgical approach) to treat it. Researchers want to understand outcomes and improve treatment for this serious condition.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain caused by spontaneous bleeding. It aims to improve recovery for patients who meet specific criteria, such as clot size and time since symptoms started.
This trial tests whether using a small camera and a tube to very quickly remove a brain bleed through a tiny hole in the skull improves recovery compared to standard medical care. It is for people who have a large, non-traumatic brain hemorrhage and can have surgery within a few hours of the bleed.
Hear when a new Supratentorial Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.